Full Press Release Details
Mechelen, Belgium; 24 August 2022, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that management will participate in the following upcoming investor conferences:
Citi’s 17th Annual Biopharma Conference. September 8, 2022 in Boston
Morgan Stanley 20th Global Healthcare Conference. September 12-14, 2022 in New York
Bank of America Merrill Lynch Global Healthcare Conference. September 15, 2022 in London
KBC Securities Virtual Life Sciences Conference. September 16, 2022
JP Morgan CEO Call Series. September 28, 2022
Credit Suisse 31st Annual Healthcare Conference. November 8-10, 2022 in Rancho Palos Verdes, CA
Bryan Garnier Virtual Conference on Cell Therapy Innovation. November 14, 2022
Jefferies 2022 Global Healthcare Conference. November 16-17, 2022 in London
Kepler Cheuvreux Virtual Life Science Days. November 21, 2022
Deutsche Bank 2022 Call Series. November 30, 2022
Additional information regarding these events will be available on the investor section of the Galapagos website at glpg.com/events.
Head of Investor Relations
Director Investor Relations
Head of Corporate Communication
Forward-looking statements
This release may contain forward-looking statements. Such forward-looking statements are not guarantees of future results. These forward-looking statements speak only as of the date of publication of this document. Galapagos expressly disclaims any obligation to update any forward-looking statements in this document, unless specifically required by law or regulation.
Galapagos to present at upcoming investor conferences
Attachments
Galapagos to present at upcoming investor conferences...